SCHEMBL7839059

SCHEMBL7839059

CCOC(=O)Oc1c(C)nc(-c2ccccn2)nc1-c1ccccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
TSHR P16473 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAPK14 Q16539 3/20 0.42
LMNA P02545 1/20 0.41
CDC7 O00311 1/20 0.41
DBF4 Q9UBU7 1/20 0.41
GRM5 P41594 1/20 0.40
METAP1 P53582 2/20 0.40
FFAR1 O14842 1/20 0.40
METAP2 P50579 1/20 0.40
KDM4E B2RXH2 2/20 0.39
HTT P42858 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPT P10636 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7839276 0.69 ALDH1A1 (0.39) ALDH1A1LMNACDC7DBF4KDM4E
SCHEMBL8946850 0.67 KDM4E (0.62) ALDH1A1TSHRLMNACDC7DBF4
SCHEMBL2724098 0.66 LMNA (0.50) ALDH1A1TDP1LMNAMETAP1FFAR1
SCHEMBL17479130 0.66 CDC7 (0.49) ALDH1A1TSHRLMNACDC7DBF4
SCHEMBL4766667 0.66 JMJD6 (0.58) ALDH1A1CDC7DBF4KDM4EHPGD
SCHEMBL3224320 0.66 LMNA (0.55) ALDH1A1TSHRLMNAKDM4EHTT
SCHEMBL12143473 0.65 METAP1 (0.73) TDP1GRM5METAP1FFAR1METAP2
SCHEMBL2951237 0.65 ALDH1A1 (0.55) ALDH1A1TSHRTDP1LMNACDC7
SCHEMBL1561125 0.65 LMNA (0.48) ALDH1A1TDP1LMNAMETAP1METAP2
SCHEMBL10375284 0.65 RAB9A (0.62) ALDH1A1TSHRLMNAKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1073642-A1 THE USE OF DIHYDROPYRIMIDINES AS MEDICAMENTS, AND NOVEL SUBSTANCES BAYER AG (DE) 2001-02-07 EP disclosed
WO-1999054312-A1 THE USE OF DIHYDROPYRIMIDINES AS MEDICAMENTS, AND NOVEL SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 1999-10-28 WO disclosed